Stock DICE DICE THER
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

DICE THER

Equities

DICE

US23345J1043

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about DICE THER

S&P 500 Edges Down Weekly as US Consumer Prices Moved Modestly Higher in July, Technology, Materials Weigh MT
Global markets live: Allianz, Generali, Sony, Disney, Alibaba... Our Logo
Trending : Lilly Gets Price Target Increases, Closes DICE Purchase DJ
Eli Lilly Completes Acquisition of DICE Therapeutics MT
Eli Lilly Wraps Up Acquisition of Dice Therapeutics MT
DICE Therapeutics, Inc.(NasdaqGM:DICE) dropped from NASDAQ Composite Index CI
DICE Therapeutics, Inc.(NasdaqGM:DICE) dropped from S&P Pharmaceuticals Select Industry Index CI
DICE Therapeutics, Inc.(NasdaqGM:DICE) dropped from S&P Global BMI Index CI
DICE Therapeutics, Inc.(NasdaqGM:DICE) dropped from S&P TMI Index CI
Eli Lilly and Company completed the acquisition of DICE Therapeutics, Inc. from a group of shareholders. CI
DICE Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
DICE Therapeutics, Inc.(NasdaqGM:DICE) dropped from NASDAQ Biotechnology Index CI
Eli Lilly Extends Tender Offer to Acquire DICE Therapeutics to Aug. 9 MT
Eli Lilly Extends $2.4 Billion Tender Offer to Buy DICE Therapeutics MT
MoonLake Immunotherapeutics explores sale-sources RE
North American Morning Briefing : Stock Futures -2- DJ
Needham Downgrades DICE Therapeutics to Hold From Buy MT
DICE Therapeutics, Inc.(NasdaqGM:DICE) dropped from Russell 3000E Index CI
DICE Therapeutics, Inc.(NasdaqGM:DICE) dropped from Russell Microcap Index CI
DICE Therapeutics, Inc.(NasdaqGM:DICE) dropped from Russell Microcap Value Index CI
DICE Therapeutics, Inc.(NasdaqGM:DICE) dropped from Russell 3000E Value Index CI
DICE Therapeutics, Inc.(NasdaqGM:DICE) added to Russell 3000E Growth Index CI
DICE Therapeutics, Inc.(NasdaqGM:DICE) added to Russell 2500 Growth Index CI
DICE Therapeutics, Inc.(NasdaqGM:DICE) added to Russell 3000 Growth Index CI
DICE Therapeutics, Inc.(NasdaqGM:DICE) added to Russell Small Cap Comp Growth Index CI

Chart DICE THER

Chart DICE THER
More charts

Company Profile

DICE Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing oral therapeutics against well-validated targets in immunology. The Company's platform, DELSCAPE, is designed to discover selective oral small molecules with the potential to modulate protein-protein interactions (PPIs). The Company's therapeutic candidate, DC-806, is an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17 (IL-17), which is a validated drug target implicated in a variety of immunology indications. The Company is also developing oral therapeutic candidates targeting a4B7 integrin for the treatment of inflammatory bowel disease (IBD) and evaluating oral therapeutic candidates targeting aVB1/aVB6 integrin for the treatment of fibrosis.
Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. DICE Stock
  4. News DICE THER
  5. DICE Therapeutics : BofA Securities Starts DICE Therapeutics at Buy with $41 Price Target